Announcements
Radiopharm Theranostics
ASX Announcements
Stay fully informed with all investment-related announcements from Radiopharm Theranostics lodged with the ASX, including financial results, clinical trial updates, and corporate governance.
Recent News
Categories
Tags
Archives
Archives
RSS
- Radiopharm Theranostics Achieves Confirmed Durable PartialResponse in Ongoing Phase 1 Trial of RAD204 in Patients withAdvanced Solid Tumors Post-Immunotherapy
- Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases
- RAD Presentation July 2026
- Zacks Small-Cap Research 2026
- Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
- Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
Analyst Reports
Analyst Coverage
| Analyst | Firm |
|---|---|
| John Hester | Bell Porter (Australia) |
| Yuan Zhi, PhD | B. Riley Securities |
| Kemp Dolliver, CFA | Brookline Capital Markets |
| Justin Walsh, PhD | Jones Trading |
| Jason McCarthy, PhD | Maxim Group |
| Ashok Kumar, PhD, CFA | Think Equity |
| John D. Vandemosten | Zacks Small Cap Research |
| Robert Burns | H.C. Wainwright & Co |
